Food and Drug Administration (FDA) said on Wednesday that Novo Nordisks experimental weekly insulin, Awiqli, carried a higher risk of hypoglycemia low blood sugar for patients with type 1 diabetes, compared with traditional daily insulin
How is PlexusDx tirzepatide different in terms of side effects
Borre M, Qvist N, Raahave D, Worsoe J, JP AE, Christensen P, Krogh K
However, published scientific research has not yet shown this effect definitively
Much literature to date has focused on the risk for drug-induced acute pancreatitis attributed to hyperstimulation of acinar cells 14,15
Whether different products can be used together depends on their individual formulations and the directions provided with each product